A Phase 1 Safety Study of Avelumab Plus Stereotactic Body Radiation Therapy in Malignant Pleural Mesothelioma.
Rimner A, Adusumilli PS, Offin MD, Solomon SB, Ziv E, Hayes SA, Ginsberg MS, Sauter JL, Gelblum DY, Shepherd AF, Guttmann DM, Eichholz JE, Zhang Z, Ritter E, Wong P, Iqbal AN, Daly RM, Namakydoust A, Li H, McCune M, Gelb EH, Taunk NK, von Reibnitz D, Tyagi N, Yorke ED, Rusch VW, Zauderer MG.
Rimner A, et al. Among authors: gelb eh.
JTO Clin Res Rep. 2022 Dec 1;4(1):100440. doi: 10.1016/j.jtocrr.2022.100440. eCollection 2023 Jan.
JTO Clin Res Rep. 2022.
PMID: 36590015
Free PMC article.